他汀类药物效益最大化与不良反应最小化 - Suppr | 超能文献

Maximizing Benefits and Minimizing Adverse Effects of Statins.

作者信息

Schade David S, Blankenship James, Eaton R Philip

机构信息

Division of Endocrinology, University of New Mexico School of Medicine, Albuquerque, New Mexico.

Division of Cardiology, University of New Mexico School of Medicine, Albuquerque, New Mexico.

出版信息

Endocr Pract. 2024 Jan;30(1):83-85. doi: 10.1016/j.eprac.2023.07.029. Epub 2023 Aug 2.

DOI:10.1016/j.eprac.2023.07.029

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Maximizing Benefits and Minimizing Adverse Effects of Statins.他汀类药物效益最大化与不良反应最小化

Endocr Pract. 2024 Jan;30(1):83-85. doi: 10.1016/j.eprac.2023.07.029. Epub 2023 Aug 2.

2

HMG CoA reductase inhibitors (statins) for dialysis patients.用于透析患者的HMG CoA还原酶抑制剂（他汀类药物）。

Cochrane Database Syst Rev. 2013 Sep 11;2013(9):CD004289. doi: 10.1002/14651858.CD004289.pub5.

3

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.肾移植受者使用的HMG CoA还原酶抑制剂（他汀类药物）

Cochrane Database Syst Rev. 2014 Jan 28;2014(1):CD005019. doi: 10.1002/14651858.CD005019.pub4.

4

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.用于非透析慢性肾病患者的HMG辅酶A还原酶抑制剂（他汀类药物）

Cochrane Database Syst Rev. 2014 May 31(5):CD007784. doi: 10.1002/14651858.CD007784.pub2.

5

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.用于非透析慢性肾病患者的HMG辅酶A还原酶抑制剂（他汀类药物）

Cochrane Database Syst Rev. 2009 Apr 15(2):CD007784. doi: 10.1002/14651858.CD007784.

6

Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.他汀类药物用于成人心血管疾病预防：美国预防服务工作组的证据报告和系统评价

JAMA. 2016 Nov 15;316(19):2008-2024. doi: 10.1001/jama.2015.15629.

7

HMG-CoA reductase inhibitors (statins) versus placebo for people with schizophrenia.用于精神分裂症患者的HMG辅酶A还原酶抑制剂（他汀类药物）与安慰剂的对比研究

Cochrane Database Syst Rev. 2025 Sep 19;9(9):CD014565. doi: 10.1002/14651858.CD014565.

8

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.他汀类药物治疗慢性肾脏病患者的获益和危害：系统评价和荟萃分析。

Ann Intern Med. 2012 Aug 21;157(4):263-75. doi: 10.7326/0003-4819-157-4-201208210-00007.

9

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.用于肾移植受者的HMG CoA还原酶抑制剂（他汀类药物）。

Cochrane Database Syst Rev. 2009 Apr 15(2):CD005019. doi: 10.1002/14651858.CD005019.pub3.

10

Statins for the primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。

Cochrane Database Syst Rev. 2011 Jan 19(1):CD004816. doi: 10.1002/14651858.CD004816.pub4.

引用本文的文献

1

Reducing Cardiovascular Disease-An Alternative Approach.降低心血管疾病——一种替代方法。

Cardiovasc Drugs Ther. 2024 Dec;38(6):1083-1087. doi: 10.1007/s10557-024-07600-1. Epub 2024 Jul 8.